Postmenopausal Hormone May Reduce Glaucoma Risk

Eye Care & Surgery Center NJ Bladeless LASIK Laser Cataract Surgeon Blog

Tuesday, January 20, 2015

Postmenopausal Hormone May Reduce Glaucoma Risk

Among the known glaucoma riskfactors such as family history, smoking, diabetes, age and race, it is also known that women who have an early onset of menopause also seem to be at greater risk of glaucoma-which suggests a role of female hormones in glaucoma risk.

Research on Postmenopausal Hormones & Glaucoma Risk
According to researchers publishing in JAMA Ophthalmology taking estrogen only postmenopausal hormone (PMH) treatment may help reduce the risk for primary open-angle glaucoma (POAG). By reviewing data from 152,163 women 50 years or older the researchers found that 1.9% of enrollees developed POAG. Each additional month of use of PMH containing estrogen only was associated with a 0.4 percent reduced risk for POAG whereas each additional month of use of estrogen + progesterone or estrogen + androgen hormones did not affect risk for POAG. This is interesting information and will require further prospective clinical studies to understand fully but may offer some novel treatments for primary open angle glaucoma (POAG), an insidious sight threatening eye diseases and the most common type of glaucoma.

If you or someone you know has a question about postmenopausal hormones and glaucoma risk or any glaucoma risk factors or needs and eye exam and glaucoma testing, please call The Eye Care & Surgery Center at 908-789-8999, visit The Eye Care & Surgery Center or to schedule an appointment.

The Eye Care & Surgery Center is located at 592 Springfield Avenue, Westfield, New Jersey 07090, 10 Mountain Boulevard, Warren, New Jersey 07059 and 517 Route One South, Suite 1100, Iselin, New Jersey 08830, and is conveniently located for patients from throughout central and northern New Jersey.